                            NIH Public Access
                            Author Manuscript
                            Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                           Published final edited form 
NIH-PA Author Manuscript




                            Int J Biochem Cell Biol. 2008 ; 40(11): 2560â€“2571. doi:10.1016/j.biocel.2008.05.003.



                           Expression, essentiality, microtiter plate assay                            mycobacterial GlmU, bifunctional glucosamine-1-phosphate
                           acetyltransferase N-acetylglucosamine-1-phosphate
                           uridyltransferase

                           Wenli Zhang1, Victoria C. Jones2, Michael S. Scherman2, Sebabrata Mahapatra2, Dean
                           Crick2, Suresh Bhamidi2, Yi Xin3, Michael R. McNeil2*, Yufang Ma1,4*
                           1Department Biochemistry Molecular Biology, Dalian Medical University, Dalian 116044, China
                           2Department Microbiology, Immunology Pathology, Colorado State University, Fort Collins,
                           Colorado 80523, USA
NIH-PA Author Manuscript




                           3Department Biotechnology, Dalian Medical University, Dalian 116044, China
                           4Liaoning Provincial Core Lab Glycobiology Glycoengineering, Dalian 116044, China

                           Abstract
                                UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) essential precursor peptidoglycan                                 rhamnose-GlcNAc linker region mycobacterial cell wall. Mycobacterium tuberculosis H37Rv
                                genome, Rv1018c shows strong homology GlmU protein involved formation UDP-
                                GlcNAc bacteria. GlmU bifunctional enzyme catalyzes sequential steps                                 UDP-GlcNAc biosynthesis. Glucosamine-1-phosphate acetyl transferase catalyzes formation                                 N-acetylglucosamine-1-phosphate, N-acetylglucosamine-1-phosphate uridylyltransferase
                                catalyzes formation UDP-GlcNAc. inhibition peptidoglycan synthesis results
                                cell lysis, M. tuberculosis GlmU potential anti-tuberculosis drug target. study cloned
                                M. tuberculosis Rv1018c (glmU gene) expressed soluble GlmU protein E. coli BL21(DE3).
                                Enzymatic assays showed M. tuberculosis GlmU protein exhibits glucosamine-1-phosphate
                                acetyltransferase N-acetylglucosamine-1-phosphate uridylyltransferase activities.                                 investigated effect Mycobacterium smegmatis activity GlmU fully removed NIH-PA Author Manuscript




                                reduced genetic approach. results showed activity GlmU required growth                                 M. smegmatis bacteria did grow absence active GlmU enzyme.                                 functional GlmU enzyme gradually reduced temperature shift experiment, M.
                                smegmatis cells non-viable morphology changed normal rod shape stubby-
                                rounded morphology cases lysed. Finally microtiter plate based assay GlmU
                                activity OD340 read developed. studies support                                 development M. tuberculosis GlmU enzyme target new anti-tuberculosis drugs.




                            corresponding authors: Yufang Ma, Department Biochemistry Molecular Biology, Dalian Medical University, Dalian 116044,
                           China. Email: yufang_ma@hotmail.com. Fax: +86-411-86110139. Phone: +86-411-86110307; Michael McNeil, Department                            Microbiology, Immunology Pathology, Colorado State University, Fort Collins, Colorado 80523, USA. Email:
                           mmcneil@colostate.edu. Fax: (970) 491-1815. Phone: (970) 491-1784.
                           Publisher's Disclaimer: PDF file unedited manuscript accepted publication. service customers
                           providing early version manuscript. manuscript undergo copyediting, typesetting, review resulting
                           proof published final citable form. note production process errors discovered                            affect content, legal disclaimers apply journal pertain.
                            Zhang et al.                                                                                                  Page 2



                              Keywords
                                    Mycobacterium tuberculosis; Mycobacterium smegmatis; GlmU; glucosamine-1-phosphate
NIH-PA Author Manuscript




                                    acetyltransferase; N-acetylglucosamine-1-phosphate uridylyltransferase


                              1. Introduction
                                             emergence drug resistant strains bacteria problem                                              controlling infectious disease (Peterson, 2005). especially true case                                              tuberculosis. Tuberculosis (TB) remains major threat world health; world-wide
                                             statistics million people developing active tuberculosis nearly fourth                                              dying disease stark reality (Dye et al.1999).  Global Alliance TB
                                             drug Development www.tballiance.org.) TB, public health problem,                                              complicated lack wide array chemotherapeutics causative agent,
                                             Mycobacterium tuberculosis,  emergence drug-resistant strains                                              line drugs large problem recent years. current line anti-TB
                                             drug regimens achieve 99  efficacy, reduced drug
                                             resistance (O'Brien Nunn, 2001). Multiple drug resistant TB (MDR-TB), bacillus
                                             resistant line drugs used fearsome type resistance; 
                                              strains resistant second line antibiotics appearing (Gandhi et al.,
NIH-PA Author Manuscript




                                             2006; Van Rie Enarson, 2006); dubbed extreme drug resistant TB (XDR-
                                             TB).

                                             mycobacterial cell wall core consists layers (McNeil Brennan, 1991; Lee et al.,
                                             2006). highly impermeable outer layer composed mycolic acids lipids
                                             containing 70 90 carbons. inner layer consists peptidoglycan. layers                                              covalently tethered connecting polysaccharide arabinogalactan (McNeil Brennan,
                                             1991; Lee et al., 2006), attached peptidoglycan disaccharide linker,
                                             Î±-L-rhamnosyl-(1,3)-Î±-D-GlcNAc-(phosphate).  GlcNAc essential component                                              peptidoglycan  bacteria) rhamnose-GlcNAc linker cell wall                                              mycobacteria.

                                             E.coli (Mengin-Lecreulx Vanheijenoort, 1994; Riley et al., 2006), enzymes
                                             catalyze sequential steps biosynthesis UDP-GlcNAc, activated nucleotide
                                             sugar GlcNAc. glutamine fructose-6-phosphate transferase, encoded glmS gene,
                                             catalyzes fructose-6-phosphate glutamine glucosamine-6-phosphate glutamate,                                              phosphoglucosamine mutase, encoded glmM gene, converts glucosamine-6-phosphate
                                             (GlcNH2-6-P) glucosamine-1-phosphate (GlcNH2-1-P). GlmU encoded glmU NIH-PA Author Manuscript




                                             bifunctional enzyme. activity GlmU, glucosamine-1-phosphate acetyltransferase,
                                             catalyzes formation N-acetylglucosamine-1-phosphate (GlcNAc-1-P)                                              glucosamine-1-phosphate using acetyl-CoA acetyl donor. second activity GlmU,
                                             N-acetylglucosamine-1-phosphate uridylyltransferase, catalyzes formation UDP-
                                             GlcNAc GlcNAc-1-P uridine triphosphate (UTP). active sites reside                                              C N terminal regions protein respectively (Olsen Roderick, 2001). Analysis                                              genome sequence Mycobacterium tuberculosis H37Rv shown protein
                                             encoded M. tuberculosis Rv3436c, Rv3441c Rv1018c homologous E. coli GlmS,
                                             GlmM, GlmU, respectively.  propose mycobacteria                                              biosynthetic pathway UDP-GlcNAc E. coli (Fig. 1). Antibiotics attacking
                                             peptidoglycan synthesis, Î²-lactams glycopeptides result cell death typically
                                             lysis (Holtje, 1995), reason attractive. GlmS GlmM
                                             catalyze reactions identical similar eukaryotes. reaction



                                              Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                                Page 3


                                          catalyzed GlmU unique prokaryotes GlmU important potential
                                          drug target.
NIH-PA Author Manuscript




                                          study, expressed M. tuberculosis GlmU protein E. coli BL21(DE3) identified
                                          GlmU glucosamine-1-phosphate acetyltransferase N-acetylglucosamine-1-
                                          phosphate uridylyltransferase. determine effect active GlmU mycobacterial
                                          growth, prepared M. smegmatis glmU knockout strain complemented M.
                                          tuberculosis glmU rescue plasmid temperature sensitive replication. Finally
                                          developed microtiter plate based assay activity.

                              2. Materials methods
                              2.1 BACTERIAL STRAINS PLASMIDS
                                          characteristics bacterial strains plasmids used study described Table
                                          1. E. coli DH5Î±, NovaBlue BL21(DE3) cells grown Luria-Bertani (LB) broth                                           LB agar 37Â°C routinely. M. smegmatis mc2155 cells grown LB broth containing
                                          0.05  Tween 80 LB agar 37Â°C routinely. Sucrose added LB agar final
                                          concentration 10  selecting M. smegmatis glmU knockout strain ZW-2. Incubation
                                          M. smegmatis ZW-2 strain carrying temperature sensitive rescue plasmid 30Â°
                                          C (permissive temperature) 42Â°C (non-permissive temperature) respectively.
NIH-PA Author Manuscript




                                          final concentration antibiotics used study follows: ampicillin (Amp), 100
                                          Âµg mlâˆ’1; gentamicin (Gen), 5 Âµg mlâˆ’1 E. coli M. smegmatis; kanamycin (Kan), 50 Âµg
                                          mlâˆ’1 E. coli 25 Âµg mlâˆ’1 M. smegmatis; streptomycin (Str), 20 Âµg mlâˆ’1 E.
                                          coli 10 Âµg mlâˆ’1 M. smegmatis.

                              2.2 CLONING GENETIC MANIPULATION
                                          Cloning procedures performed according standard protocols (Sambrook Russell,
                                          2001). M. smegmatis mc2155 genomic DNA prepared previously described (Jackson
                                          et al., 2000). Probe Southern blotting labeled digoxygenin (DIG)-labeled
                                          dUTP using DIG High Prime Labeling Detection Starter Kit (Roche). SmaI-
                                          digested M. smegmatis genomic DNA fragments separated 0.8  agarose gel                                           transferred Nytran membrane (Whatman Schleicher Schuell) described (Li et al.,
                                          2006). DNA hybridization detection performed according Rocheâ€™s instructions.

                              2.3 CLONING, EXPRESSION PURIFICATION M. TUBERCULOSIS GLMU E. COLI
                              MURA MURB
                                          M. tuberculosis glmU gene (Rv1018c) amplified M. tuberculosis H37Rv
NIH-PA Author Manuscript




                                          genomic DNA (supplied Colorado State University NIH contract â€œTuberculosis
                                          research materials vaccine testing.â€?) using Mtb glmU1 primer, 5â€™
                                          CATATGACGTTTCCTGGTGACAC 3â€™ (underlined sequence NdeI site) Mtb
                                          glmU2 primer, 5â€™ CTCGAGTCACGGTGTCTGATCAGCGTC 3â€™ (underlined sequence                                           XhoI site). amplified PCR product ligated pBluescript II KS(âˆ’) (Strategene)                                           generate plasmid pBS-Mtb glmU (Table 1). Following sequence confirmation Mtb glmU
                                          gene ligated NdeI XhoI sites pET-16b (Novagen), resulting pET16b-
                                          Mtb glmU (Table 1). pET16b-Mtb glmU transformed E. coli BL21(DE3) expression
                                          GlmU protein.

                                          E. coli BL21(DE3) containing pET16b-Mtb glmU grown 2 liters LB broth containing
                                          Amp overnight 37Â°C. cells transferred shaker room temperature induced
                                          overnight addition isopropyl-D-thiogalactopyranoside (IPTG) final concentration
                                          0.1 mM. cells harvested pellets resuspended 20 ml lysis prep buffer (20


                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                              Page 4


                                          mM Tris-HCl, pH 8.0, 500 mM NaCl, 20  glycerol) 1 ÂµM leupeptin, 1 ÂµM pepstatin 
                                          1 mM phenylmethylsulphonyl fluoride (PMSF). cells broken using French
                                          Pressure method, followed centrifugation 20 000 x g 40 minutes. supernatant NIH-PA Author Manuscript




                                          applied 1.5 ml column volume Select HF affinity gel (Sigma). column washed
                                          40 ml wash buffer (lysis prep buffer 20 mM imidazole, pH 8.0). protein                                           eluted 15 ml elute buffer (20 mM Tris-HCl, 500 mM NaCl, 20  glycerol, 200 mM
                                          imidazole, pH 7.0) 1 ÂµM leupeptin, 1 ÂµM pepstatin  1 mM PMSF, 5
                                          ml collected testing.

                                          purified protein run 12  SDS-PAGE transferred nitrocellulose membrane
                                          (Whatman Schleicher Schuell) blotting buffer (20 mM Tris-base, 150 mM glycine                                           20  methanol). membrane blocked 2  BSA TBST buffer (10 mM Tris-HCl,
                                          pH 8.0, 150 mM NaCl, 0.05  Tween 20) incubated (anti)-polyhistidine clone 1
                                          antibody (Sigma) 1 6000 dilution followed washing TBST. membrane                                           incubated antimouse-IgG-AP conjugate (Sigma) protein band visualized                                           BCIP/NBT solution.

                                          gene murA amplified E. coli K12 genomic DNA following                                           primers incorporating NcoI SmaI restriction enzyme sites (underlined): 5â€™
                                          AACTCCATGGATAAATTTCGTGTTCAG 3â€™ 5â€™
                                          AGACCCGGGTTCGCCTTTCACACGC 3â€™. PCR products digested NcoI
NIH-PA Author Manuscript




                                          SmaI, ligated expression vector pTYB4, previously digested                                           NcoI SmaI. E. coli murB gene amplified E. coli genomic DNA                                           following primers incorporating NcoI SmaI restriction enzyme sites (underlined)                                           cloned pTYB4: GCAGCCATGGACCACTCCTTAAAACC                                           GTTATCCCGGGTGAAATTGTCTCCAC. pTYB4-Ec murA pTYB4-Ec murB                                           transformed ER2566 respectively. expressed E. coli MurA E.coli MurB proteins                                           purified IMPACTâ„¢ Protein Purification according New England Biolabsâ€™
                                          instructions.

                              2.4 DETERMINATION ACETYL TRANSFERASE URIDYLYLTRANSFERASE
                              ACTIVITIES M. TUBERCULOSIS GLMU PROTEIN
                                          acetyl transferase uridylyltransferase activities M. tuberculosis GlmU protein                                           determined separately. acetyl transferase activity, reaction mixture contained 100
                                          ÂµM acetyl CoA glucosamine-1-phosphate 10 mM Tris buffer (0.1 mM MgCl2
                                          0.01  Triton X 100, pH 8). transacetylation carried addition 100
                                          ng GlmU (purified) crude M. smegmatis extract reaction incubated 30
                                          minutes room temperature. control experiment, addition enzyme source,
                                          substrates buffer carried  incubation, NIH-PA Author Manuscript




                                          reaction mixture dried cleaned glass tube mild hydrolysis carried                                           0.2 mM TFA (Trifluroacetic acid) 80Â°C 1 hour. tubes cooled room
                                          temperature dried. drying repeated twice presence methanol.                                           followed acetylation 1:1 deutero acetic anhydride/pyridine, overnight. drying
                                          solvents, acetylated products extracted D2O:CHCl3 (1:1) chloroform
                                          layer subjected GC/MS. acetylated-derivatives dissolved chloroform prior
                                          injection DB-5 column initial temperature 50Â°C held 1 min. temperature
                                          increased 275Â°C rate 5Â°C/min. mass spectral analysis carried positive
                                          CI mode collision gas methane. starting material showed M+H-63 ion
                                          3 AMU higher product non-deuterated methyl group product.

                                          determine uridylyltransferase active, enzyme reaction run reverse
                                          direction PPi UDP-GlcNAc GlcNAc-1-P UTP (Mengin-Lecreulx                                           Vanheijenoort, 1994). reaction performed 40 Âµl total volume containing 25 ÂµM

                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                           Page 5


                                          UDP-GlcNAc, 1 mM pyrophosphate (PPi) 42 Âµg/ml GlmU protein 50 mM Tris-HCl
                                          (pH 8.2) containing 1 mM MgCl2. incubation 37Â°C 30 minutes, reaction                                           run Beckman HPLC 30 minute gradient starting 100  75 mM
NIH-PA Author Manuscript




                                          KH2PO4 ending 100  500 mM KH2PO4.

                                          microtiter plate assay, GlmU activity linked MurA MurB E. coli.
                                          assay run combining 4 Âµg purified M. tuberculosis GlmU, 0.6 Ã¬g purified E. coli
                                          MurA 80 ng purified E. coli MurA 80 Âµl 200 mM Tris containing 10 mM MgCl2, 200
                                          ÂµM NADPH, 20 mM KCl 96 plate. reaction started                                           adding 20 Âµl 200 mM Tris, 10 mM MgCl2 containing 1 mM UTP, 1 mM acetyl CoA, 1 mM
                                          glucosamine-1-phosphate, 1 mM phosphoenol pyruvate. Absorbance 340 nm                                           followed 45 minutes 30Â°C Benchmark Plus (Bio-Rad) plate reader data                                           analyzed using Microsoft Excel.

                              2.5 CONSTRUCTION SUICIDE PLASMID RESCUE PLASMID
                                          amino acid sequence M. tuberculosis H37Rv GlmU protein
                                          (http://genolist.pasteur.fr/TubercuList/) used query BLASTP identify                                           homologous gene M. smegmatis mc2155 genome. M. smegmatis glmU gene
                                          (MSMEG_5426) 75  identical homology Rv1018c. M. smegmatis
                                          glmU (1449 bp) upstream region (491 bp) amplified mc2155 genomic DNA
                                          using LA Taq DNA polymerase (Takara), glmU1 primer
NIH-PA Author Manuscript




                                          (5â€™ACTAGTCTCGACACGGACCCGGGAGC 3â€™, underlined sequence SpeI site)                                           glmU2 primer (5â€™TGCGGCCGCTCAGCTCTCGTCGCCCAACG3â€™, underlined
                                          sequence NotI site). PCR product 1947 bp purified cloned pMD18-T
                                          vector (Takara) generate plasmid plasmid pZW-1 (Table 1). glmU gene disrupted
                                          inserting kanamycin resistance cassette (kanR) pUC4K (GE Healthcare), yielding
                                          pZW-2 (Table 1). pZW-2 digested NotI SpeI resulting glmU::kanR
                                          fragment (3.1 kb) ligated NotI SpeI sites pPR27-xylE (Li et al., 2006),
                                          resulting suicide plasmid pZW-3 (Table 1). parent plasmid pPR27 (Pelicic et al.,
                                          1997) shuttle vector containing replication origins E.coli mycobacteria.
                                          Specifically, replication origin mycobacteria mutations resulting plasmid
                                          replication temperature sensitive mycobacteria.  pZW-3 replicates                                           permissive temperature (30Â°C), replicate non-permissive temperature (42Â°C),
                                          resulting integration M. smegmatis genome intact glmU gene                                           glmU::kanR present.

                                          M. tuberculosis glmU gene amplified M. tuberculosis H37Rv genomic DNA using
                                          Mtb glmU1 primer, 5â€™ CATATGACGTTTCCTGGTGACAC 3â€™ (underlined sequence                                           NdeI site)â€™ Mtb glmU3 primer, 5â€™GGATCCTCACGGTGTCTGATCAGCGTC
NIH-PA Author Manuscript




                                          3â€™ (underlined sequence BamHI site). PCR product M. tuberculosis glmU cloned
                                          pMD18-T vector generate plasmid pZW-4 (Table 1). M. tuberculosis glmU gene
                                          ligated NdeI BamHI sites pET23b-Phsp60 (Li et al., 2006), yielding                                           pZW-5 (Table 1). Phsp60-Mtb glmU ligated XbaI BamHI sites pCG76
                                          (Guilhot et al., 1994), resulting rescue plasmid pZW-6 (Table 1). M. tuberculosis
                                          glmU gene transcribed promoter heat shock protein 60 M. bovis BCG
                                          M. tuberculosis GlmU protein complemented glmU::kanR M. smegmatis ZW-2.                                           parent plasmid pCG76 temperature-sensitive mycobacterial replication origin                                           pPR27 replicate 30Â°C, effectively lost 42Â°C.

                              2.6 SELECTION M. SMEGMATIS GLMU KNOCKOUT STRAIN ZW-2
                                          M. smegmatis electrocompetent cells prepared described (Pelicic et al., 1997)                                           suicide plasmid pZW-3 electroporated competent cells Gene Pulser (Bio-


                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                              Page 6


                                           Rad). Transformants grown LB agar plates containing Kan Gen 30Â°C.                                            colony propagated LB broth containing 0.05  Tween 80, Kan Gen 30Â°C,
                                           cells plated LB agar plate containing Kan Gen incubated NIH-PA Author Manuscript




                                           42Â°C colonies appeared. M. smegmatis ZW-1 (Table 1) integrated pZW-3                                            glmU locus selected using Southern blot.

                                           pZW-6 rescue plasmid electroporated ZW-1 cells. Transformants grown                                            LB agar plate containing Kan Str, incubated 30Â°C. Transformants                                            plated LB agar plate containing Kan, Str 10  sucrose. M. smegmatis ZW-2
                                           (glmU gene knockout strain) (Table 1) confirmed using Southern blot.

                              2.7 MONITORING GROWTH M. SMEGMATIS ZW-2
                                           growth M. smegmatis ZW-2 followed monitoring optical density (OD)                                            600 nm cultures measuring colony forming units (CFU). M. smegmatis ZW-2                                            inoculated 2 tubes containing 5 ml LB broth 0.05  Tween 80 appropriate
                                           antibiotics, cells incubated 30Â°C 42Â°C respectively. M. smegmatis mc2155
                                           M. smegmatis mc2155 pZW-6 used controls. OD600 detected                                            interval 24 hours growth curves 30Â°C 42Â°C obtained.

                                           measure CFU M. smegmatis ZW-2 cells grown LB broth containing 0.05  Tween
                                           80 Kan 30Â°C OD600 reached 0.10, cells transferred 42Â°C
NIH-PA Author Manuscript




                                           incubator. OD600 cells grown 42Â°C determined interval 24 hours.
                                           CFU determinations (taken time points), dilutions spread LB agar
                                           plates containing Str Kan. plates incubated 30Â°C CFU counted.

                              2.8 DETECTION M.TUBERCULOSIS GLMU PROTEIN M. SMEGMATIS ZW-2
                                           M. smegmatis ZW-2 cells grown 30Â°C (OD600 0.10) switched 42Â°C incubator.
                                           ZW-2 cells kept growing 30Â°C controls. cells harvested interval
                                           24 hours pellets resuspended lysis prep buffer 1 mM PMSF. cells                                            broken sonication followed centrifugation 20 000 x g 30 minutes. supernatants
                                           run 10  SDS-PAGE Western blot performed described 2.3.                                            membrane incubated anti-M. smegmatis GlmU serum mouse,                                            prepared lab (unpublished data), incubated antimouse-IgG-AP conjugate
                                           (Sigma). protein band visualized BCIP/NBT solution.

                              2.9 MORPHOLOGY M. SMEGMATIS ZW-2 42 Â°C
                                           effects decreasing GlmU activity morphology ZW-2 examined                                            scanning electron microscopy (SEM) time points CFUs determined.
NIH-PA Author Manuscript




                                           cells washed times 0.1 M Phosphate buffer (pH 7.4) fixed 2.5 
                                           glutaraldehyde 1  OsO4 followed dehydration graded series ethanol (20,
                                           40, 60, 70, 80, 90, 100 ). cell pellet resuspended 100  ethanol, applied silicon
                                           wafer slide, gold coated thickness 5 nm. cells examined JSM-6500F
                                           scanning electron microscope  Central Instrumentation Facility, Colorado State
                                           University) using accelerating voltage 15 kV.

                              3. Results
                              3.1. INITIAL IDENTIFICATION GLMU MYCOBACTERIA
                                           amino acid sequence encoded M. tuberculosis H37Rv gene Rv1018c expected                                            encoded GlmU homology bacterial GlmU proteins. sequence                                            used query BLASTP identify homologous gene M. smegmatis mc2155
                                           genome. M. smegmatis glmU gene (MSMEG_5426) 75  identical

                                           Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                              Page 7


                                          homology Rv1018c. sequence alignment mycobacterial GlmU proteins
                                          E. coli GlmU protein shown Fig. 2. confirm presence GlmU M.
                                          smegmatis, conversion GlcNH2-1-P GlcNAc-1-P, N-acetylase activity GlmU
NIH-PA Author Manuscript




                                          shown occur crude M. smegmatis extracts (Fig. 3c) using GC/MS method shown
                                          Fig. 3a.

                              3.2 EXPRESSION PURIFICATION M. TUBERCULOSIS GLMU PROTEIN
                                          M. tuberculosis glmU gene cloned NdeI XhoI sites pET16b yielding
                                          N-terminal histidine tag GlmU fusion protein expected molecular weight                                           54.10 kD. M. tuberculosis GlmU expressed soluble protein E. coli BL21(DE3)
                                          induction 0.1 mM IPTG room temperature purified Ni2+ affinity
                                          chromatography. Purified M. tuberculosis GlmU protein determined expected
                                          size SDS-PAGE Western blot analysis (Fig. 4).

                              3.3 ACETYL TRANSFERASE URIDYLYLTRANSFERASE ACTIVITIES M.
                              TUBERCULOSIS GLMU PROTEIN
                                          acetyl transferase purified M. tuberculosis GlmU protein demonstrated using                                           GC/MS assay shown Fig. 3d. uridylyltransferase activity shown reverse
                                          direction UDP-GlcNAc converted UTP GlcNAc-1-P. incubation                                           UDP-GlcNAc PPi 30 minutes lead complete disappearance UDP-GlcNAc (Fig.
NIH-PA Author Manuscript




                                          5c) control reaction (Fig. 5b), PPi included reaction mixture,
                                          lead reaction.

                              3.4 GENERATION M. SMEGMATIS GLMU GENE KNOCKOUT STRAIN ZW-2
                                          M. smegmatis mc2155 transformants pZW-3 selected LB agar plates containing
                                          Kan Gen 30Â°C colonies turned yellow catechol sprayed plates.
                                          yellow colonies propagated LB broth containing 0.05  Tween 80, Kan Gen
                                          30Â°C, spread LB agar plates containing Kan Gen 42Â°C. pZW-3
                                          plasmid unable replicate 42Â°C, Kan resistant colonies plates necessarily
                                          integrated glmU::kanR glmU locus M. smegmatis mc2155 genome. M.
                                          smegmatis transformant arose single homologous recombination event                                           glmU locus (ZW-1) confirmed Southern blot.

                                          rescue plasmid pZW-6 electroporated M. smegmatis ZW-1, generation                                           M. smegmatis ZW-2 (glmU knockout strain)  grow LB agar containing Kan 10 
                                          sucrose) selected  M. smegmatis ZW-2 strains confirmed Southern blot
                                          (Fig. 6). strains showed expected bands 1.0 kb (faint), 1.59 kb 1.79 kb. band
                                          1.34 kb missing, confirming loss intact glmU gene. bands 0.65 kb,
NIH-PA Author Manuscript




                                          0.80 kb 5.3 kb pZW-6 plasmid.

                              3.5 ESSENTIALITY GLMU GENE MYCOBACTERIAL GROWTH
                                          order determine GlmU required mycobacterial growth, growth curves                                           M. smegmatis ZW-2 30Â°C 42Â°C obtained (Fig. 7A). results clearly showed
                                          M. smegmatis ZW-2 grew 30Â°C, 42Â°C pZW-6                                           replicate. contrast, M. smegmatis mc2155 M. smegmatis mc2155 containing pZW-6
                                          grew 30Â°C 42Â°C.  results showed M. tuberculosis glmU gene
                                          essential mycobacterial growth.

                                          M. smegmatis ZW-2 grown 30Â°C 0.10 OD600, culture switched                                           incubator 42Â°C. CFU OD600 time obtained shown Fig. 7B.                                           functional GlmU protein produced M. smegmatis ZW-2 cells 30Â°C, cells


                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                                 Page 8


                                          multiplied 24 hours temperature shift (Fig. 7B). dramatically,                                           increased incubation time 42Â°C, CFUs dropped GlmU decreased.
                                          Western blot data (Fig. 7C) confirmed expected loss GlmU protein, 1 day
NIH-PA Author Manuscript




                                          insufficient GlmU detection western blot seen (Fig 7C lane 3).

                              3.6 MORPHOLOGICAL CHANGES M. SMEGMATIS ZW-2 42Â°C
                                          UDP-GlcNAc important precursor peptidoglycan mycobacterial cell wall,
                                          expected change morphology possibly lysis bacteria biosynthesis
                                          decreased.  temperature switched 30Â°C 42Â°C, morphology
                                          M. smegmatis ZW-2 grown 42Â°C 24, 48, 72, 96 hours observed SEM.
                                          morphology M. smegmatis ZW-2 30Â°C just switching 42Â°C (Fig. 8A)                                           indistinguishable M. smegmatis mc2155 wild type (Fig. 8G). time, M. smegmatis
                                          ZW-2 cells 42Â°C dramatically shorter rounder (Fig. 8B, C D). M.
                                          smegmatis ZW-2 cells 42Â°C 96 hours showed evidence lysis (Fig. 8E F).                                           SEM results suggest lack GlmU activity result profound negative effects                                           bacterial cell morphology.

                              3.7 DEVELOPMENT MICROTITER PLATE ASSAY GLMU
                                          Given desirability GlmU drug target designed microtiter plate based assay
                                          detect activity. assay (Fig. 1) relies enzymes MurA MurB convert
NIH-PA Author Manuscript




                                          UDP-GlcNAc UDP-MurNAc concomitant reduction NADPH. E. coli
                                          MurA MurB cloned expressed E coli resulting proteins purified                                           described material methods. evident Fig. 9, enzymes substrates
                                          present NADPH oxidized concomitant decrease OD340.

                              4. Discussion
                                          UDP-GlcNAc essential precursor peptidoglycan rhamnose-GlcNAc linker region
                                          mycobacterial cell wall. pathway UDP-GlcNAc biosynthesis significantly
                                          different eukaryotes prokaryotes. eukaryotes, N-acetylation occurs GlcNH2-6-P
                                          GlcNH2-1-P. second reaction, formation UDP-GlcNAc UTP                                           GlcNAc-1-P, prokaryotes eukaryotes. eukaryotes, uridylyltransferase
                                          activity carried distinct monofunctional enzymes little sequence homology                                           GlmU.  tertiary structure active site eukaryotic enzymes responsible                                           uridylyltranserase activity similar uridylyltransferase active site prokaryotic
                                          enzymes (Peneff et al., 2001a; Peneff et al., 2001b). Given similarity, acetylation
                                          reaction considered attractive drug target bacteria.
NIH-PA Author Manuscript




                                          shown M. tuberculosis GlmU protein distinct activities;
                                          glucosamine-1-phosphate acetyltransferase N-acetylglucosamine-1-phosphate
                                          uridylyltransferase. mycobacteria, GlmU enzyme clearly essential,                                           knocked M. smegmatis grow presence rescue plasmid containing                                           M. tuberculosis glmU gene, grow rescue plasmid does replicate.
                                          Insertional mutagenesis studies using transposon site hybridization (TraSH) methodology
                                          reported M. tuberculosis glmU essential gene (Sassetti et al.2003);                                           extended determine fate bacteria gene turned (Fig 7 & Fig 8).                                           experimental approach somewhat limited GlmU enzyme abruptly turned
                                           replication rescue plasmid containing functional M. tuberculosis
                                          glmU gene stopped. results decrease GlmU present cell                                           time. SEM data showed dramatic change morphology including appeared lysis
                                          cells latest time point. cells cleanly broken half happens
                                          Î²-lactams, cells appear ruptured (Fig. 8E F).  

                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                                        Page 9


                                          essentiality GlmU effect loss activity mycobacterial cells strongly
                                          support development target new TB drugs. Potentially, new drugs                                           similar bactericidal properties Î²-lactams. assay developed microtiter plates
NIH-PA Author Manuscript




                                          allows inhibitors acetyl transferase uridylyltransferase screened
                                          

                                          Inhibitors GlmU important terms inhibiting linker region                                           mycobacterium cell wall. previously demonstrated effects knocking                                           rhamnosyl formation enzymes, RmlD (Ma et al., 2002) Rml B RmlC (Li et al.,
                                          2006). Assays inhibitors RmlC RmlD proceeding NIH Roadmap screening
                                          center. work validates develops techniques appropriate similar screening                                           GlmU inhibitors.

                              Acknowledgement
                                          work supported funds provided National Basic Research Program China (2006CB504400),
                                          National Natural Science Foundation China (30670454) National Institute Health (USA) (AI 33706).


                              References
                                          Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global Surveillance Monitoring
                                             Project. Consensus statement. Global burden tuberculosis: estimated incidence, prevalence, NIH-PA Author Manuscript




                                             mortality country. Journal American Medical Association 1999;282:677â€“686.
                                          Gandhi NR, Moll  Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G.
                                             Extensively drug-resistant tuberculosis cause death patients infected tuberculosis
                                             HIV rural area South Africa. Lancet 2006;368:1575â€“1580. [PubMed: 17084757]
                                          Guilhot C, Otal  Van Rompaey  Martin C, Gicquel B. Efficient transposition mycobacteria:
                                             construction Mycobacterium smegmatis insertional mutant libraries. Journal Bacteriology
                                             1994;176:535â€“539. [PubMed: 8288551]
                                          Holtje JV. growth autolysis: murein hydrolases Escherichia coli. Archives Microbiology
                                             1995;164:243â€“254. [PubMed: 7487333]
                                          Jackson M, Crick DC, Brennan PJ. Phosphatidylinositol essential phospholipid mycobacteria.
                                             Journal Biological Chemistry 2000;275:30092â€“30099. [PubMed: 10889206]
                                          Kostrewa D, D'Arcy  Takacs B, Kamber M. Crystal structures Streptococcus pneumoniae N-
                                             acetylglucosamine-1- phosphate uridyltransferase, GlmU, apo form 2.33 resolution                                              complex UDP-N-acetylglucosamine Mg(2+) 1.96 resolution. Journal Molecular Biology
                                             2001;305:279â€“289.
                                          Lee  Wu SW, Scherman MS, Torrelles JB, Chatterjee D, McNeil MR, Khoo KH. Sequencing                                              oligoarabinosyl units released mycobacterial arabinogalactan endogenous arabinanase:
                                             identification distinctive novel structural motifs. Biochemistry 2006;45:15817â€“15828.
NIH-PA Author Manuscript




                                             [PubMed: 17176104]
                                          Li W, Xin Y, McNeil MR, Ma Y. rmlB rmlC genes essential growth mycobacteria.
                                             Biochemical Biophysical Research Communications 2006;342:170â€“178. [PubMed: 16472764]
                                          Ma Y, Pan F, McNeil MR. Determination dTDP-rhamnose formation essential growth                                              mycobacteria. J.Bacteriol 2002;184:3392â€“3395. [PubMed: 12029057]
                                          Mengin-Lecreulx D, Vanheijenoort J. Copurification glucosamine-1-phosphate acetyltransferase                                                N-acetylglucosamine-1-phosphate uridylyltransferase activities Escherichia coli: characterization
                                               glmU gene product bifunctional enzyme catalyzing subsequent steps pathway
                                               UDP-N-acetylglucosamine synthesis. Journal Bacteriology 1994;176:5788â€“5795. [PubMed:
                                               8083170]
                                          McNeil MR, Brennan PJ. Structure, function, biogenesis cell envelope mycobacteria                                                relation bacterial physiology, pathogenesis, drug resistance; thoughts possibilities
                                               arising recent structural information. Research Microbiology 1991;142:451â€“463. [PubMed:
                                               1871433]



                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                                     Page 10


                                          O'Brien RJ, Nunn PP. need new drugs tuberculosis, Obstacles, opportunities,                                               steps. American Journal Respiratory Critical Care Medicine 2001;163:1055â€“1058. [PubMed:
                                              11316634]
NIH-PA Author Manuscript




                                          Olsen LR, Roderick SL. Structure Escherichia coli GlmU pyrophosphorylase acetyltransferase
                                              active sites. Biochemistry 2001;40:1913â€“1921. [PubMed: 11329257]
                                          Olsen LR, Vetting MW, Roderick SL. Structure E. coli bifunctional GlmU acetyltransferase active
                                              site substrates products. Protein Science 2007;16:1230â€“1235. [PubMed: 17473010]
                                          Pelicic V, Jackson M, Reyrat JM, Jacobs WR Jr, Gicquel B, Guilhot C. Efficient allelic exchange                                               transposon mutagenesis Mycobacterium tuberculosis. Proceedings National Academy                                               Sciences 1997;94:10955â€“10960.
                                          Peneff C, Mengin-Lecreulx D, Bourne Y. crystal structures Apo complexed Saccharomyces
                                              cerevisiae GNA1 shed light catalytic mechanism amino-sugar N-acetyltransferase.
                                              Journal Biological Chemistry 2001;276:16328â€“16334. [PubMed: 11278591]
                                          Peneff C, Ferrari P, Charrier V, Taburet Y, Monnier C, Zamboni V, Winter J, Harnois M, Fassy F, Bourne
                                              Y. Crystal structures human pyrophosphorylase isoforms complexes UDPGlc(Gal)
                                              NAc: role alternatively spliced insert enzyme oligomeric assembly active site
                                              architecture. EMBO Journal 2001;20:6191â€“6202. [PubMed: 11707391]
                                          Peterson LR. Squeezing antibiotic balloon: impact antimicrobial classes emerging resistance.
                                              Clinical Microbiology Infection 2005;11:4â€“16. [PubMed: 16138814]
                                          Riley M, Abe T, Arnaud MB, Berlyn MK, Blattner FR, Chaudhuri RR, Glasner JD, Horiuchi T, Keseler
                                              IM, Kosuge T, Mori H, Perna NT, Plunkett G III, Rudd KE, Serres MH, Thomas GH, Thomson NR,
NIH-PA Author Manuscript




                                              Wishart D, Wanner BL. Escherichia coli K-12: cooperatively developed annotation snapshot-2005.
                                              Nucleic Acids Research 2006;34:1â€“9. [PubMed: 16397293]
                                          Sambrook, J.; Russell, DG. Molecular Cloning: Laboratory Manual. 3 rd ed. New York: Cold Spring
                                              Harbor Laboratory Press; 2001.
                                          Sassetti CM, Boyd DH, Rubin EJ. Genes required mycobacterial growth defined high density
                                              mutagenesis. Molecular Microbiology 2003;48:77â€“84. [PubMed: 12657046]
                                          Van Rie  Enarson D. XDR tuberculosis: indicator public-health negligence. Lancet
                                              2006;368:1554â€“1556. [PubMed: 17084741]
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                        Page 11
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 1.
                                            Biosynthetic pathway UDP-GlcNAc formation mycobacteria. GlmU (Rv1018c)                                           bifunctional enzyme glucosamine-1-phosphate acetyl transferase N-
                                          acetylglucosamine-1-phosphate uridylyl transferase activities. (B) reactions MurA                                           MurB act UDP-GlcNAc product GlmU used linked assay                                           loss NADPH monitored. bacterium, product, UDP-MurNAc, NIH-PA Author Manuscript




                                          converted peptidoglycan.




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                             Page 12
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 2.
                                          Sequence alignment glmU E. coli, M. tuberculosis M. smegmatis. symbol â€œ.â€?
                                          indicates breaks inserted order obtain best alignment.
                                          sequence underlines indicate uridylyl transferase active site (Kostrewa et al., 2001).
                                          active site acetylation involves amino acids adjacent, interacting beta
                                          helices depicted follows: bold letters Acetyl Coenzyme binding amino
                                          acids, bold italics letters amino acids bind glucosamine-1-phosphate
                                          (Olsen et al., 2007). numbering end line sequences refers                                           amino acid number speciesâ€™ sequence. Consensus 1 shows homology M.
                                          tuberculosis M. smegmatis sequences (second lines) compared                                           Consensus 2 shows homology sequence organisms   second,                                           lines) compared. symbols used Consensus 1 Consensus 2 follows:
                                          â€œ.â€? means consensus  upper case abbreviation amino acid means                                           perfect consensus present; lower case abbreviation amino acid means imperfect
NIH-PA Author Manuscript




                                          consensus amino acid present sequence. symbols
                                          indicate closely related amino acids  â€œ!â€? V 
                                          â€œ$â€? L M  â€œ â€? F Y  â€œ#â€? N, D, Q,                                           E 




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                            Page 13
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 3.
                                          Determination GlmU acetyl transferase activity.   preparation tetra-O-
                                          perdeuterioacetyl-N-perdeuterioacetyl derivative starting GlcNH2-1-phosphate                                           tetra-O-perdeuterioacetyl-N-acetyl derivative product GlcNAc-1-phosphate. D6Ac2O =
                                          hexadeuterioacetic anhydride. (B) M+H-63 ion (63 weight trideuterio acetic acid)
                                          detected GC/MS (CI mode) analysis derivatization reactants incubated buffer
                                          enzyme (control reaction). (C) M+H-63 ion detected GC/MS (CI mode) analysis
                                          derivatization reactants incubated buffer crude M. smegmatis enzymes. (D)
                                          M+H-63 ion detected GC/MS (CI mode) analysis derivatization reactants
                                          incubated buffer M. tuberculosis GlmU expressed E. coli. C D starting

                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                        Page 14


                                          material fully converted product. acetyl transferase activity incubations                                           200 Âµl 10 mM Tris buffer (0.1 mM MgCl2 0.01  Triton X 100), pH 8 containing 100
                                          ÂµM acetyl CoA glucosamine-1-phosphate. 100 ng purified M.
NIH-PA Author Manuscript




                                          tuberculosis GlmU (D), 0.5 Âµg crude M. smegmatis extract (C), enzyme (B)                                           added reactions incubated 30 minutes room temperature derivatization.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                           Page 15
NIH-PA Author Manuscript




                                          Fig. 4.
                                          Analysis purified M. tuberculosis GlmU protein SDS-PAGE   Western blot
                                          (B). Lane 1. PageRuler prestained protein ladder (Fermentas,  170, 130,
NIH-PA Author Manuscript




                                          100, 70, 55, 40, 35, 25 kD); Lane 2. purified M. tuberculosis GlmU protein  histidine tag)
                                          (5 Âµg) expected molecular weight 54.10 kD. (anti)-polyhistidine clone 1
                                          antibody 1 6000 dilution used Western blot analysis (B).
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                      Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 5.
NIH-PA Author Manuscript




                                          uridylyl transferase activity GlmU enzyme assayed HPLC.   UDP-GlcNAc
                                          standard, (B) UDP-GlcNAc GlmU PPi, (C) UDP-GlcNAc GlmU                                           PPi. enzyme reactions incubated 37Â°C 30 minutes 40 Âµl 50 mM Tris-HCl
                                          (pH 8.2) containing 1 mM MgCl2, 25 ÂµM UDP-GlcNAc, 1 mM pyrophosphate (PPi)  C
                                          , 42 Âµg/ml GlmU protein.




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                       Page 17
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 6.
                                          Southern blot analysis M. smegmatis ZW-2 strains.
                                            expected DNA fragments M. smegmatis mc2155. (B) expected DNA fragments
                                          M. smegmatis ZW-2. (C) Confirmation M. smegmatis ZW-2 strains Southern blot.
                                          Lanes 1â€“6. M. smegmatis ZW-2 strains hybridized DNA bands 1.0 kb, 1.59 kb,
                                          1.79 kb; Lane 7. pZW-6 hybridized DNA bands 0.65 kb, 0.8 kb 5.3 kb; Lane
                                          8. M. smegmatis mc2155 wild type hybridized DNA bands 1.34 kb 1.79 kb. (D)
                                          map plasmid pCG76-Mtb glmU (pZW-6) rescue plasmid.
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                            Page 18
NIH-PA Author Manuscript




                                          Fig. 7.
                                          Growth curves M. smegmatis ZW-2 strain.
                                            Growth curves M. smegmatis ZW-2 strain 30Â°C 42Â°C. M. smegmatis ZW-2                                           30Â°C (â–²); M. smegmatis ZW-2 42Â°C (â–¡). M. smegmatis mc2155 30Â°C (â—?); M.
NIH-PA Author Manuscript




                                          smegmatis mc2155 42Â°C (â—‹). M. smegmatis mc2155 carrying pZW-6 30Â°C (â– ); M.
                                          smegmatis mc2155 carrying pZW-6 42Â°C (â–¡). (B) CFU growth curve ZW-2.                                           cells grown 30Â°C 24 hours transferred 42Â°C incubator. CFU                                           OD600 M. smegmatis ZW-2 grown 42Â°C determined interval 24 hours. Log
                                          CFUs M. smegmatis ZW-2 (â–²); OD600 M. smegmatis mc2155 ZW-2 42Â°C (â—?).
                                          (C) Western blot GlmU showing loss temperature shift. antibody                                           M. smegmatis GlmU cross reacts M. tuberculosis GlmU. Lanes  1. purified M.
                                          tuberculosis GlmU protein  histidine tag) (54.10 kD); 2. PageRulerâ„¢ Prestained Protein
                                          Ladder (Fermentas), MW protein visualized 55 kD; 3, 5, 7, 9. M. smegmatis ZW-2
                                          grown 42Â°C 1, 2, 3, 4 days shifting temperature 30Â°C 42Â°C; 4, 6, 8, 10.
                                          M. smegmatis ZW-2 grown 30Â°C 1, 2, 3 4 days. molecular weight M.
                                          tuberculosis GlmU expressed pCG76-Mtb glmU M. smegmatis ZW-2 50.29 kD.
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                       Page 19
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 8.
                                          Scanning electron micrographs M. smegmatis ZW-2 strain.
                                            M. smegmatis ZW-2 cells grown 30Â°C 24 hours just transfer 42Â°C (10
                                          000X); (Bâ€“E) M. smegmatis ZW-2 cells 42Â°C 24; 48, 72 96 hours (10 000X); (F)
                                          M. smegmatis ZW-2 cells 42Â°C 96 hours  E) higher magnification (30
                                          000X); (G) Wild type M. smegmatis control. Arrows (E) (F) point areas possible
                                          lysis.
NIH-PA Author Manuscript




                                          Int J Biochem Cell Biol. Author manuscript; available PMC 2009 January 1.
                            Zhang et al.                                                                                          Page 20
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Fig. 9.
                                          GlmU, MurA MurB 96 plate assay.
                                          enzymatic activity M. tuberculosis GlmU determined 96 plate format
                                          utilizing MurA MurB,  E. coli) NADPH. enzymes present (â—Š)
                                          A340 drops (average slope âˆ’0.0054, standard deviation 0.00013) loss NADPH.
                                          substrates omitted reaction (Î” acetyl Coenzyme (average slope
                                          âˆ’0.0007, standard deviation 0.00033), â—‹ - glucosamine-1-phosphate (average slope
                                          âˆ’0.0005, standard deviation 0.00023), Ã— - phosphoenol pyruvate (average slope âˆ’0.0008,
                                          standard deviation 0.00018) â–¡ - UTP (average slope âˆ’0.0006, standard deviation
NIH-PA Author Manuscript




                                          0.00017)) A340 does decrease. Similar lack activity seen (data presented                                           graph) enzymes left  GlmU (average slope âˆ’0.00094,
                                          standard deviation 0.000012), MurA (average slope âˆ’0.00043, standard deviation 0.00012)
                                          MurB (average slope âˆ’0.0006, standard deviation 0.00019).




                                 